Latest Prescription Drugs news
Ocrelizumab Provides Superior Relapse Control in Multiple Sclerosis
posted October 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
posted October 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Women With Autism May Experience More Severe Menopause 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
